Expression of BAG-1 in invasive breast carcinomas

Journal of Clinical Oncology

Volumn 17, Issue 6, 1999, Pages 1710-1719

  Tang, Shou Ching ^a   Shaheta, Nadine ^a   Chernenko, Garry ^a   Khalifa, Mohmoud ^a   Wang, Xikui ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER SURVIVAL; CELLULAR DISTRIBUTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033002905     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.6.1710     Document Type: Article

References (40)

1. Lipponen P, Aaltomaa S, Kosma VM, et al: Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A:2068-2073, 1994
2. Nathan B, Gusterson B, Jadayel D, et al: Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. Ann Oncol 5:409-414, 1994
3. Bhargava V, Kell DL, van de Rijn M, et al: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Ann J Pathol 145:535-540, 1994
4. Gee JMW, Robertson JFR, Ellis IO, et al: Immunocytochemical localization of Bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 59:619-628, 1994
5. Hori M, Nogami T, Itabashi M, et al: Expression of Bcl-2 in human breast cancer: Correlation between hormone receptor status, p53 protein accumulation and DNA strand breaks associated with apoptosis. Pathol Int 47:757-762, 1997
6. Joensuu H, Pylkkänen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994
7. Ceccarelli C, Santini D, Chieco P, et al: Multiple expression patterns of biopathological markers in primary invasive breast carcinoma: A useful tool for elucidating its biological behaviour. Annals of Oncol 6:275-282, 1995
8. Lipponen P, Pietilainen T, Kosma VM, et al: Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177:49-55, 1995
9. Barbareschi M, Caffo O, Veronese S, et al: Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up. Human Pathol 27:1149-1155, 1996
10. Visscher DW, Sarkar F, Tabaczka P. et al: Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma. Mod Pathol 9:642-646, 1996
11. Sundlad AS, Ahn C, Battifora A: Immunohistochemical detection of bcl-2 and MIB-1/Ki-67 in breast cancer: Retrospective analysis of 238 cases. Medicina (B Aires) 56:252-258, 1996
12. Kobayashi S, Iwase H, Ito Y, et al: Clinical significance of bcl-2 gene expression in human breast cancer tissues. Breast Cancer Res Treat 42:173-181, 1997
13. Kapranos N, Karaiosifidi H, Valavanis C, et al: Prognostic significance of apoptosis related proteins Bcl-2 and Bax in node-negative breast cancer patients. Anticancer Res 17:2499-2505, 1997
14. Olopade OI, Adeyanju MO, Safa AR, et al: Over-expression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3:230-237, 1997
15. Krajewski S, Blomqvist C, Franssila K, et al: Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471-4478, 1995
16. Aas T, Borresen AL, Geisler S, et al: Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2:811-814, 1996
17. Linn SC, Honkoop AH, Hoekman K, et al: p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br J Cancer 74:63-68, 1996
18. Degeorges A, de Roquancourt A, Extra JM, et al: Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer? Breast Cancer Res Treat 47:47-55, 1998
19. Tang S-C, Visser L, Hepperle B, et al: Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases. J Clin Oncol 12:149-154, 1994
20. Takayama S, Sato T, Krajewski S, et al: Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279-284, 1995
21. Bardelli A, Longati P, Albero D, et al: HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J 15:6205-6212, 1996
22. Clevenger CV, Thickman K, Ngo W, et al: Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol Endocrinol 11:608-618, 1997
23. Sekiya M, Adachi M, Takayams S, et al: IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells. Biochem Biophys Res Commun 239:401-406, 1997
24. Terada S, Fukuoka K, Fujita T, et al: Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology 25:17-23, 1997
25. Takaoka A, Adachi M, Okuda H, et al: Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14:2971-2977, 1997
26. Zeinet M, Gehring U: A protein that interacts with members of the nuclear hormone receptor family: Identification and cDNA cloning. Proc Natl Acad Sci U S A 92:11465-11469, 1995
27. Kullmann M, Schneikert J, Moll J, et al: RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J Biol Chem 273:14620-14625, 1998
28. Froesch BA, Takayama S, Reed JC: BAG-1L protein enhances androgen receptor function. J Biol Chem 273:11660-11666, 1998
29. Yang X, Chernenko G, Hao Y, et al: Human BAG-1/RAP46 proteins are generated as four isoforms by alternative translation initiation and overexpressed in human cancer cells. Oncogene 17:981-989, 1998
30. Yang X, Hao Y, Pater A, et al: Differential expression of anti-apoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues. Clin Cancer Res (in press)
31. Zapata JM, Krajewska M, Krajewski S, et al: Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumours. Breast Cancer Res Treat 47:129-140, 1998
32. Höhfeld J, Jentsch S: GrpE-like regulation of the Hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J 16:6209-6216, 1997
33. Takayama S, Bimston DN, Matsuzawa S, et al: BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J 16:4887-4896, 1997
34. Elledge RM, Green S, Howes L, et al: Bcl-2, p53 and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: A Southwest Oncology Group study. J Clin Oncol 15:1916-1922, 1997
35. Berarda MD, Elledge RM, de Moor C, et al: Bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 82:1296-1302, 1998
36. Silvestrini R, Veneroni S, Daidone MG, et al: The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499-504, 1994
37. Hellemans P, van Dam PA, Weyler J, et al: Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72:354-360, 1995
38. Papadimitriou CS, Costopoulos JS, Christoforidou BP, et al: Expression of Bcl-2 protein in human primary breast carcinomas and its correlation with multifocality, histopathological types and prognosis. Eur J Cancer 33:1275-1280, 1997
39. Sierra A, Lloveras B, Castellsague X, et al: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60:54-60, 1995
40. Gorczyca W, Markiewski M, Kram A, et al: Innumohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: Their correlation with Ki-67 growth fraction. Virchows Arch 426:229-233, 1995